Squarepoint Ops LLC Alkermes Plc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 189,650 shares of ALKS stock, worth $5.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

189,650

Previous 217,151 12.66%

Holding current value

$5.33 Million

Previous $5.23 Million 1.43%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $632,798 - $785,153	-27,501 Reduced 12.66%	189,650 $5.31 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $8.04 Million - $9.44 Million	-346,368 Reduced 61.47%	217,151 $5.23 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $2 Million - $2.47 Million	-75,715 Reduced 11.84%	563,519 $15.3 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $14.3 Million - $17.5 Million	611,272 Added 2186.08%	639,234 $17.7 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $918,612 - $1.09 Million	-32,414 Reduced 53.69%	27,962 $875,000
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $994,556 - $1.14 Million	39,295 Added 186.4%	60,376 $1.7 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $2.32 Million - $2.78 Million	-105,892 Reduced 83.4%	21,081 $550,000
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $70,290 - $101,824	-3,195 Reduced 2.45%	126,973 $2.84 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $209,008 - $241,785	7,917 Added 6.48%	130,168 $3.88 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $1.27 Million - $1.55 Million	55,219 Added 82.38%	122,251 $3.22 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $4.91 Million - $7.34 Million	-228,862 Reduced 77.35%	67,032 $1.56 Million
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $814,304 - $1.12 Million	34,844 Added 13.35%	295,894 $9.13 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $1.49 Million - $2 Million	79,326 Added 43.65%	261,050 $6.4 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $2.09 Million - $2.66 Million	114,758 Added 171.37%	181,724 $3.4 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $483,461 - $694,249	-31,414 Reduced 31.93%	66,966 $1.34 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $1.59 Million - $2.03 Million	98,380 New	98,380 $1.63 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $1.69 Million - $2.46 Million	-126,671 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $122,790 - $199,698	9,402 Added 8.02%	126,671 $1.83 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $39,058 - $49,110	2,259 Added 1.96%	117,269 $2.39 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $3.89 Million - $4.83 Million	-199,132 Reduced 63.39%	115,010 $2.24 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $5.68 Million - $9.87 Million	264,522 Added 533.1%	314,142 $7.08 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $1.46 Million - $1.87 Million	-51,284 Reduced 50.82%	49,620 $1.81 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $1.6 Million - $2.56 Million	57,311 Added 131.47%	100,904 $2.98 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $119,621 - $142,925	3,099 Added 7.65%	43,593 $1.85 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $1.33 Million - $1.69 Million	32,869 Added 431.07%	40,494 $1.67 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $96,069 - $120,529	-1,792 Reduced 19.03%	7,625 $442,000
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $11,493 - $13,348	-241 Reduced 2.5%	9,417 $515,000
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $474,787 - $525,878	9,658	9,658 $491,000

Others Institutions Holding ALKS

# of Institutions

364

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.61B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Alkermes Plc. Transaction History